Bionano Genomics (BNGO) Non-Current Deffered Revenue (2017 - 2026)
Bionano Genomics recorded quarterly Non-Current Deffered Revenue of $143000.0 in Q1 2026, down 42.57% quarter-over-quarter from $249000.0 in Q4 2025, and down 51.03% year-over-year from $292000.0 in Q1 2025.
Bionano Genomics' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $143000.0 for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue fell 51.03% year-over-year to $143000.0; the TTM figure through Mar 2026 stood at $143000.0 (down 51.03% YoY), while the FY2025 annual figure was $249000.0, down 6.74% from the prior year.
- Non-Current Deffered Revenue came in at $143000.0 for Q1 2026 at Bionano Genomics, down from $249000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $292000.0 in Q1 2025 to a low of $127000.0 in Q4 2022.
- A 5-year average of $196647.1 and a median of $192000.0 in 2025 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue jumped 111.59% in 2025 and slumped 51.03% in 2026, its largest moves.
- Bionano Genomics' Non-Current Deffered Revenue stood at $127000.0 in 2022, then rose by 21.26% to $154000.0 in 2023, then surged by 73.38% to $267000.0 in 2024, then fell by 6.74% to $249000.0 in 2025, then slumped by 42.57% to $143000.0 in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $143000.0, $249000.0, and $192000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 163.15 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 11.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 206.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Bionano Genomics | 14.92 Mn | 539,417.67 | 3.25 Mn | 143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 267,000.00 |
| Sep 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 151,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 136,000.00 |
| Jun 30, 2022 | 203,000.00 |
| Mar 31, 2022 | 133,000.00 |
| Dec 31, 2021 | 146,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 108,000.00 |
| Dec 31, 2020 | 98,000.00 |
| Sep 30, 2020 | 88,000.00 |
| Jun 30, 2020 | 84,000.00 |
| Mar 31, 2020 | 127,000.00 |
| Dec 31, 2019 | 182,648.00 |
| Sep 30, 2019 | 224,088.00 |
| Jun 30, 2019 | 219,202.00 |
| Mar 31, 2019 | 304,467.00 |
| Dec 31, 2018 | 304,467.00 |
| Sep 30, 2018 | 144,602.00 |
| Dec 31, 2017 | 142,929.00 |